Fairfield Financial Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10
| Closed | -$416 | – | 146 |
|
|
2024
Q4 | $416 | Hold |
10
| – | – | ﹤0.01% | 255 |
|
|
2024
Q3 | $668 | Sell |
10
-35
| -78% | -$2.34K | ﹤0.01% | 281 |
|
|
2024
Q2 | $5.34K | Buy |
+45
| New | +$5.34K | ﹤0.01% | 239 |
|
|
2023
Q4 | $68.5K | Sell |
689
-609
| -47% | -$60.6K | 0.03% | 119 |
|
|
2023
Q3 | $134K | Sell |
1,298
-635
| -33% | -$65.6K | 0.06% | 85 |
|
|
2023
Q2 | $235K | Sell |
1,933
-498
| -20% | -$60.5K | 0.09% | 64 |
|
|
2023
Q1 | $358K | Sell |
2,431
-132
| -5% | -$19.5K | 0.16% | 54 |
|
|
2022
Q4 | $460K | Sell |
2,563
-280
| -10% | -$50.3K | 0.21% | 44 |
|
|
2022
Q3 | $336K | Sell |
2,843
-42
| -1% | -$4.97K | 0.16% | 48 |
|
|
2022
Q2 | $412K | Sell |
2,885
-1,098
| -28% | -$157K | 0.19% | 44 |
|
|
2022
Q1 | $686K | Buy |
+3,983
| New | +$686K | 0.25% | 43 |
|